Skip to main content
Equibles
MNKD logo

MNKD

Mannkind Corp
$4.52 +0.47 (+11.60%) At close · Jul 2
Market Cap
$1.34B
Shares
308,950,166

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.52 Open$4.10 Day$4.08–4.55 52W$2.23–6.51 Avg vol 30d5.3M Short int31.3M · 10.1% float · 6.8d Short vol57% Last earningsMay 6, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 6
Equibles Rating blended score · not investment advice
Overall
Neutral
Technical · trend & momentum Buy
◦ 50 / 200-day cross no cross
+ Price vs 200-day avg +1% above
+ Price vs 50-day avg +31% above
◦ RSI (14) 69 · neutral
+ MACD trend positive
◦ 52-week position 54% · mid-range
Sentiment · smart money Bearish
◦ Trend (MA cross) 50d $3 › 200d $4 — 200d above 50d
− Institutional flow 2 of 253 funds reported for Jun 30 · net -1.0K sh shares
− Insider flow Net -$65.7K over 90 days · 100% sells
− Short interest 10.12% of float · ▲ +3.0% MoM · 6.8 days cover
◦ Volume signal Volume near normal
+ Institution breadth 253 holders — near 3-yr high, broad support
Fundamentals Fair
+ Revenue growth +22% Y/Y
− EPS growth −80% Y/Y
+ Free cash flow $13.7M
− Balance sheet net debt $279.8M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Aug 5, 2026 Est · unconfirmed · in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 6, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      no cross Neutral
      Price vs 200-day avg
      +1% above Bullish
      Price vs 50-day avg
      +31% above Bullish
      RSI (14)
      69 · neutral Neutral
      MACD trend
      positive Bullish
      52-week position
      54% · mid-range Neutral
      Market signals — smart money & positioning
      Bearish · 3 of 6
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Distributing
      2 of 253 funds reported for Jun 30 · net -1.0K sh shares
      Insider flow Distributing
      Net -$65.7K over 90 days · 100% sells
      Short interest Rising
      10.12% of float · ▲ +3.0% MoM · 6.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      253 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $2 Now $5 · 54% 52-wk high $7
      vs 200-day avg +1% vs 50-day avg +31%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Doses dispensed 60% through April compared to the same period last year call —
      FOURO6 doses per prescription decline 20% Q1 compared to Q4 call —
      Patients addressable by ralinepag DPI 250K across pulmonary arterial hypertension, pulmonary hypertension a call —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MNKD
      Mannkind Corp
      this stock
      		$1.34B -20.3% +22.2% — 10.1%
      AKTX
      Akari Therapeutics Plc
      		 $953.21B -9.9% — — 0.0%
      ONC
      BeOne Medicines Ltd.
      		 $470.30B -2.0% +22179.2% 957.1 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $134.02B +16.5% +46.2% 31.3 1.8%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $69.80B -15.1% +20.8% 16.3 3.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      253
      % held
      58.3%
      Reported
      2 of 253
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      159
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      31.3M
      Days to cover
      6.8d
      Change
      +923.7K sh
      View
      Short Volume
      Short vol %
      57%
      As of
      Jul 6, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      112.1K
      Value
      $406.9K
      As of
      Jun 11, 2026
      View
      Off-Exchange
      Off-exchange %
      49.9%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$65.7K
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $349.0M
      Net income (FY)
      $5.9M
      EPS diluted
      $0.02
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 2, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $56.9K
      Shares
      16.9K
      Filed
      May 12, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MNKD +15.0% +34.5% -24.8% +6.1% -20.3%
      SPY +1.4% -1.3% +8.0% -0.3% +9.2%
      vs SPY +13.6% +35.8% -32.8% +6.4% -29.5%
      Key facts CIK 899460 CUSIP 56400P706 13F (30d) 2 filings 2 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)